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Background and purpose Little is known about biochemical 
mediators that correlate with the initiation and progression of 
knee osteoarthritis (OA). We therefore valuated the roles of cyto-
kines and metalloenzymes in knee OA in relation to OA grading, 
age, and BMI.
Patients and methods   A multiplex ELISA-based immunoassay 
(Luminex technology) was used to measure biochemical media-
tors in the synovial fluid (SF) of 82 patients undergoing knee 
surgery. All patients were classified according to age, BMI, and 
OA grade. 24 patients had no signs of OA (knee reconstruction 
surgeries). The mediators that were tested for included interleu-
kins (IL-1Ra, IL-6, IL-7, and IL-18), chemokines (CCL2 (MCP-
1), CCL3 (MIP-1a), and CXCL8 (IL-8)), growth factors (HGF 
and VEGF), and matrix metalloproteinases (MMP-1, MMP-2, 
MMP-9, and MMP-13).
Results   There was a correlation between IL-7 levels in SF and 
age (p < 0.01). The 11 highest IL-7 levels were seen in patients 
who were aged between 59 and 72 but had different OA grades. 
In contrast, all patients who had severe OA in all 3 knee com-
partments (pan-OA) had only low or medium IL-7 levels. There 
was a negative correlation between MMP-1 levels in synovial fluid 
and grade of OA (p < 0.001). Correlation studies between pairs of 
mediators revealed two groups of mediators that are important in 
OA progression, dominated by MCP-1 and IL-1Ra.
Interpretation   IL-7 levels in SF are elevated in elderly people 
suffering from OA of different grades, but they are depressed in 
patients with severe 3-compartment OA, possibly due to widely 
impaired chondrocytes embedded in the affected cartilage tissue. 
The observed decrease in MMP-1 levels in SF, which is dependent 
on the severity of OA, may be caused by deterioration of superfi-
cial cartilage layers during progression of OA. 

 
Progression of knee OA is often driven by biomechanical 
forces (Englund 2010), whereas the etiology of OA in other 
joints is less affected by mechanical stress. Biochemical medi-
ators such as cytokines, growth factors, and matrix metallo-
proteinases—acting individually or in networks—profoundly 
influence cellular responses in joint tissues, modifying both 
catabolic and anabolic activities involved in the pathogene-
sis of OA (Goldring and Goldring 2007). Ageing is the most 
prominent risk factor for OA, and chondrocyte senescence 
and aging-related changes in the matrix, such as articular 
surface fibrillation and proteoglycan changes, are most likely 
to contribute to joint ageing (Martin and Buckwalter 2002, 
Shane Anderson and Loeser 2010). However, despite inten-
sive research efforts, little is known about biochemical factors 
whose levels may correlate with the severity of knee OA (Belo 
et al. 2007). Also, age-related changes in cytokine production 
in body fluids have not been investigated completely (Gardner 
and Murasko 2002).
Biochemical mediators found in synovial fluid (SF) that 
affect the cellular functions of tissues of the knee joint include 
interleukins (ILs), chemokines, growth factors, and matrix 
metalloproteinases (MMPs). Interleukins, both pro- and anti-
inflammatory, have a pivotal role in arthritic diseases and are 
potential targets of OA therapy. Chemokines, which are small, 
chemoattractant cytokines, have key roles in the accumula-
tion of inflammatory cells at the site of inflammation. Growth 
factors produced by chondrocytes and subchondral bone reg-
ulate the growth of blood vessels in the joint. Some recent 
studies have supported the notion that inhibition of abnormal 
angiogenesis will provide effective therapeutic strategies for 60  Acta Orthopaedica 2012; 83 (1): 59–64
treatment of OA (Ashraf and Walsh 2008). MMPs and pro-
inflammatory cytokines are involved in a collagen II-depen-
dent feed-forward mechanism of matrix degradation in human 
articular cartilage (Klatt et al. 2009).
To improve our understanding of the molecular and cel-
lular processes involved in joint ageing and in the initiation 
and progression of OA, we wanted to determine the levels of 
biochemical mediators that correlate with the severity of knee 
OA or patient age.
Patients and methods
Patients and their synovial fluid
Synovial fluids were collected from 82 patients who had knee 
surgery (total knee replacements or cruciate ligament, cartilage, 
or meniscal reconstruction surgeries). Patients with inflamma-
tory or arthritic diseases other than osteoarthritis and patients 
who had had traumatic events 3 weeks or less before surgery 
were excluded. 3 patients had had traumatic events 6 weeks 
or less before surgery, but it is known that increased levels of 
cytokines caused by traumatic events revert to normal levels 
within 1 week (Irie et al. 2003). All patients were grouped 
by age and grade of OA (Kellgren and Lawrence 1957). The 
breakdown of age was as follows: 29 patients were aged 17–39 
(mean age 29 (SD 7) years, 12 females), 28 patients were aged 
40–59 (mean age 47 (SD 7) years, 8 females), and 25 patients 
were aged 60–82 (mean age 68 (SD 6) years, 16 females). The 
OA groups were as follows: 24 patients without any radiologi-
cal signs of OA (OA grade 0; mean age 31 (SD 10) years, 8 
females), 31 patients with OA of grade 1 or 2 (mean age 45 
(SD 14) years, 14 females), and 27 patients with OA of grade 
3 or 4 (mean age 63 (SD 11) years, 14 female). We obtained 
informed consent and written agreement from each patient. OA 
gradings of anterior-posterior knee radiographs were scored by 
an experienced observer (KHF) who was blinded to the bio-
chemical mediator levels in the SF.
SF samples (at least 200 µL) were collected from all patients 
during surgery, centrifuged for 10 min at 1,000 g using serum 
monovettes (Sarstedt, Nümbrecht, Germany), and stored at 
–80°C until assay.
Multiplex immunoassay
Cytokines were measured in SF samples using 3 different 
multiplex detection kits: 8-plex (IL-1Ra, IL-6, IL-8 (CXCL8), 
IL-10, IL-17, monocyte chemoattractant protein (MCP)-1 
(CCL2), macrophage inflammatory protein (MIP)-1a (CCL3), 
and vascular endothelial growth factor (VEGF)), MMP-plex 
(MMP-1, MMP-2, MMP-9, and MMP-13) (both from R&D 
Systems, Minneapolis, MN), and 4-plex (IL-7, IL-13, IL-18, 
and hepatocyte growth factor (HGF); Bio-Rad Laboratories, 
Hercules, CA). In MMP-plex, total MMP was measured (pro-, 
active, and TIMP-bound forms). Total MMP-1 was also mea-
sured using ELISA (MMP-1 Biotrak ELISA; GE Healthcare, 
UK). Multiplex and ELISA assays were carried out according 
to the manufacturers’ instructions. SF samples were diluted 
4-fold in calibrator diluent or assay buffer and were measured 
in duplicate. Calculated coefficients of variation were below 
20%, and most were below 10%. For cytokine quantification 
and analysis, the Bio-Plex Suspension Array System (Man-
ager Software version 5.0; Bio-Rad Laboratories; Luminex 
platform) was used. Concentrations of 3 cytokines were not 
measurable within the dynamic range in more than 90% of 
samples: IL-10 (< 2.7 pg/mL), IL-13 (< 1.2 pg/mL), and IL-17 
(< 2.8 pg/mL). In earlier measurements IL-1a, IL-1b, inter-
feron-g, and tumor necrosis factor-a (all < 2 pg/mL) were not 
detected in most SF samples (data not shown). 
Statistics
For correlation studies, Spearman’s rank correlation coef-
ficient was used. Statistical analysis was performed using 
Smith’s Statistical Package version 2.80. Any p-values of 
< 0.05 were considered statistically significant.
Results
Interleukin-7
IL-7 levels in SF correlated more with age than with OA grade 
(Figure 1). The median value of IL-7 doubled when compar-
ing patients older than 60 years to those younger than 60 years 
(2.6 pg/mL as opposed to 1.3 pg/mL, p = 0.006).
Of all patients older than 55 years, 23 had severe OA (of grade 
3 or 4) (Figure 2). 11 of these 23 patients had severe cartilage 
lesions (ICRS grade 3 or 4) in all 3 compartments of the knee 
(pan-OA). Notably, all 11 of these patients had low or median 
Figure 1. Levels of IL-7, VEGF, and MMP-1 in SF of patients classified 
into 3 OA-grading groups (grade 0, grade 1 or 2, and grade 3 or 4) or 
3 age groups (< 40 years, 40–59 years, and > 60 years). The results 
from each individual are depicted. Bars indicate median concentra-
tions. The dashed line indicates the detection limit. Significant differ-
ences between the groups are depicted by p-values; more significant 
p-values are written in bold.
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IL-7 levels (< 2.55 pg/mL), but 9 of the 12 patients without 
pan-OA had high IL-7 levels (> 2.55 pg/mL). Spearman’s rank 
correlation coefficient between IL-7 and patient age was 0.53 
for all patients but was 0.61 for patients without pan-OA.
We also plotted IL-7 levels against BMI (Figure 3). There 
was a correlation between IL-7 levels and BMI, but to a lesser 
extent than between IL-7 levels and age. Spearman’s rank cor-
relation coefficient was 0.44, as compared to 0.53 for the cor-
relation with age. Multiple regression analysis of IL-7 levels 
against age and BMI and/or grade of OA confirmed that age 
had a major influence on IL-7 level (p < 0.002) without having 
a significant influence of BMI (p ≥ 0.1) and/or grade of OA 
(p > 0.2).
VEGF and MMP-1
VEGF levels in SF correlated more with OA grade than with 
age (Figure 1). The median value of VEGF increased 2-fold 
when comparing patients with OA of grade 0 to patients with 
OA of grade 3 or 4 (490 pg/mL vs. 1 ng/mL, p = 0.02). There 
was no correlation between VEGF levels and BMI (data not 
shown).
There was more of a negative correlation between MMP-1 
levels in SF and grade of OA than between MMP-1 levels in 
SF and age (Figure 1). The median value of MMP-1 decreased 
3-fold when comparing patients with OA of grade 0 to patients 
with OA of grade 3 or 4 (42 ng/mL vs. 13 ng/mL, p < 0.001). 
When comparing OA of grade 1 or 2 with OA of grade 3 or 4, 
the median MMP-1 level decreased 2.5-fold (33 ng/mL vs. 13 
ng/mL, p < 0.001).
Multiple regression analysis of MMP-1 levels against grade 
of OA and age and/or BMI confirmed that OA grade had a 
major influence on MMP-1 level (p < 0.004) without having 
a significant influence of age (p > 0.2) and/or BMI (p > 0.2).
Figure 3. Correlation between BMI levels and IL-7 levels in SF. Spear-
man’s rank correlation coefficient was 0.44 for all patients and 0.46 for 
patients without pan-OA. See the legend to Figure 2 for further details.
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Figure 2. Correlation between age and IL-7 levels in SF. The results 
and OA grade of each individual are depicted. Grade 0: white circles. 
Grade 1: light-gray circles. Grade 2: dark-gray circles. Grade 3: black 
circles. Grade 4: black squares. The results for OA that affected all 
3 knee compartments (pan-OA) are marked with a gray dash. The 
dashed line indicates the detection limit.
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Figure 4. Cytokine and protease levels in SF of patients with OA grade 
0, OA grade 1 or 2, or OA grade 3 or 4. The results from each individual 
are depicted. Bars indicate median concentrations. Dashed lines indi-
cate detection limits. There was no significant difference in the levels of 
any particular mediator between groups.
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To validate our findings regarding MMP-1, we confirmed 
the results using ELISA. Here, the mean value of MMP-1 
decreased 2.5-fold when comparing patients with OA of grade 
0 to patients with OA of grade 3 or 4 (153 ng/mL vs. 64 ng/
mL, p = 0.001). When comparing OA of grade 0 with OA of 
grade 1 or 2, the mean MMP-1 level decreased 1.6-fold (153 
ng/mL vs. 95 ng/mL, p = 0.031). Age-related p-values were 
much higher (133 ng/mL vs. 68 ng/mL, p = 0.011; 133 ng/mL 
vs. 100 ng/mL, p = 0.21; respectively) (data not shown).
Other mediators
The absolute levels of all other cytokines and proteases in 
SF showed no correlation with OA grade (Figure 4), age, or 
BMI (data not shown). Median values of the mediators were 
as follows. IL-6: 53 pg/mL; IL-8: 36 pg/mL; IL-18: 55 pg/mL; 
IL-1Ra: 560 pg/mL; HGF: 670 pg/mL; MCP-1: 300 pg/mL; 
MIP-1a: 34 pg/mL; MMP-2: 170 ng/mL; MMP-9: 720 pg/
mL; and MMP-13: 43 pg/mL.
Correlation coefficients
Table 1 (see supplementary data) summarizes the data on the 
relationship between the levels of 2 mediators in SF from all 
patients. Correlation coefficients of at least 0.5 were obtained 
between the level of IL-7 and age, between the levels of 
MCP-1 and VEGF, between the levels of IL-8 and IL-1Ra, 
and between the levels of IL-8 and IL-6. 
In Table 2 (see supplementary data), the data from patients 
with OA of grade 0, 1, or 2 (Table 2a) are compared with the 
data from patients with OA of grade 3 or 4 (Table 2b). For 
patients with OA of grade 0, 1 or 2, the pairs of mediators with 
correlation coefficients of at least 0.5 were identical to those 
that were observed for all patients (compare Table 2a with 
Table 1). However, for grade-0, grade-1, and grade-2 patients, 
high correlation coefficients were obtained for BMI and IL-7 
(r = 0.48) and for MMP-1 and MMP-13 or MMP-1 and IL-8 
(r = 0.48 and r = 0.51, respectively). Note also that correla-
tion coefficients between age and IL-7 decreased from 0.52 
for grade-0, grade-1, and grade-2 patients to 0.06 for grade-3 
and grade-4 patients (compare Table 2a and Table 2b) due to 
pan-OA patients with low IL-7 levels (Figure 2).
For patients with OA of grade 3 or 4, we observed 2 groups 
with very high correlation coefficients (Table 2b). The first 
group was dominated by MCP-1 (MCP-1/MMP-13: r = 0.77; 
MCP-1/VEGF: r = 0.64), and the second group was dominated 
by IL-1Ra (IL-1Ra/MMP-9: r = 0.72; IL-1Ra/IL-8: r = 0.70; 
IL-1Ra/MIP-1a: r = 0.65; IL-1Ra/HGF: r = 0.64). The high-
est increase in correlation coefficients for grade-3 and grade-4 
patients compared to grade-0, grade-1, and grade-2 patients 
was observed for MCP-1/MMP-13 in the first group and for 
HGF/IL-1Ra and HGF/IL-8 in the second group (compare 
Table 2b and Table 2a). The correlation coefficient between 
MMP-1 and MMP-13 and that between MMP-1 and IL-8 
decreased drastically (r = 0.48 vs. –0.26 and r = 0.51 vs. 0.14, 
respectively). 
Discussion
Interleukin-7
IL-7 is a multipotent cytokine that also acts as a growth factor 
and is well known for its role in peripheral T-lymphocyte 
homeostasis (Kittipatarin and Khaled 2007). It is produced by 
OA chondrocytes, and IL-7-stimulated chondrocytes respond 
with proteoglycan release from cartilage (Long et al. 2008). 
The catabolic properties of IL-7 negatively affect the cartilage 
in at least 3 ways: inflammation-driven joint destruction, T 
cell-driven bone loss, and direct, harmful effects on cartilage 
(van Roon and Lafeber 2008).
The present study suggests that the production of IL-7 in 
the articular joint is strongly age-related. IL-7 levels were 
highly elevated in SF samples from older patients suffering 
from OA that did not affect all 3 compartments, suggesting 
that IL-7 production is part of a degenerative, age-related pro-
cess that requires at least one unaffected joint compartment 
for elevated IL-7 production. It is known that IL-7 produc-
tion is increased in cultured chondrocytes from older donors, 
from OA cartilage, and after stimulation with fibronectin frag-
ments, IL-1, and IL-6 (Long et al. 2008). However, IL-7 levels 
were reduced in patients with 3-compartment OA (Figure 2), 
which could have been due to impaired cartilaginous chon-
drocytes unable to produce high amounts of IL-7. The loss 
of cartilage and chondrocytes in all 3 compartments in severe 
OA may finally lead to decreasing IL-7 levels in the SF. To our 
knowledge, this is the first observation that a cytokine level in 
SF was influenced differently by 1–2-compartment OA or by 
3-compartment OA.
We believe that there are several possibilities for the gen-
eral increase in SF IL-7 levels in elderly people (> 55 years). 
Ageing is accompanied by altered T-cell functions (Gardner 
and Murasko 2002), suggesting an effect on the expression 
of IL-7 from impaired chondrocytes that have lost their pro-
tective surroundings in fibrillated cartilage, which is common 
in elderly people (Martin and Buckwalter 2002). These age-
related changes in cartilage may also directly influence IL-7 
production. Furthermore, senescence of chondrocytes, which is 
caused by oxidative stress-induced, telomere-related genomic 
instability (Yudoh et al. 2005), may be the trigger for elevated 
IL-7 expression rates in older cartilage. Finally, other age-
related changes, such as fibronectin content in the extracellular 
matrix, changes in proteoglycans, increased collagen crosslink-
ing, and decreased water concentration (Martin and Buckwalter 
2002) may contribute to the upregulation of IL-7 expression.
VEGF and MMP-1
The angiogenic growth factor VEGF induces MMP expres-
sion in chondrocytes and mediates mainly destructive pro-
cesses in OA. Immunostaining of OA specimens revealed that 
there was a correlation between the severity of OA and VEGF 
expression in chondrocytes, suggesting that ingrowing blood 
vessels may liberate pro-apoptotic signals in articular carti-Acta Orthopaedica 2012; 83 (1): 59–64  63
lage, leading to apoptotic events in OA chondrocytes (Pfander 
et al. 2001). Our growing understanding of the causal role 
of VEGF and angiogenesis in OA has been summarized by 
Murata et al. (2008); the expression of VEGF and subsequent 
VEGF-dependent signaling in OA can be viewed as a counter-
productive process of the body in its attempt to repair the joint. 
The data from our study confirm that VEGF is an important 
mediator of OA progression.
MMP-1 is an interstitial collagenase that is capable of 
degrading interstitial collagens (types I, II, and III) and is 
thought to be a multifunctional molecule with important roles 
in diverse physiologic processes, such as development, tissue 
morphogenesis, and wound repair (Pardo and Selman 2005). 
We have shown for the first time that production of MMP-1 in 
the articular joint is reduced in patients with severe OA com-
pared to patients with no or moderate OA (Figure 1). MMP-1 
is mainly expressed in superficial cartilage zones, where chon-
drocytes deteriorate during progression of OA, while there 
is expression of other MMPs, e.g. MMP-9, in deeper zones 
(Freemont et al. 1997). In addition, we found no evidence 
that articular surface fibrillation, which is known to be indica-
tive of proteolytic changes in OA cartilage, is able to increase 
MMP-1 expression within the cartilage, either in superficial or 
in deeper zones (Nguyen et al. 1992). Furthermore, we found 
that mechanical loading of articular cartilage reduces MMP-1 
synthesis in healthy cartilage but not in OA cartilage (Monfort 
et al. 2006). A reduction in MMP-1 expression and activity 
levels is also induced by mechanical strain in fibroblast-like 
synoviocytes (Sun et al. 2003). Taking all these observations 
together, we can conclude that the reduced levels of MMP-1 
in SF of patients with advanced OA may be caused by the 
deterioration of articular cartilage in advanced OA—due to 
the loss of functional chondrocytes embedded in the cartilage. 
In contrast to our results, no significant association with radio-
graphic grading (Ahlbäck grading) was found when the sever-
ity of OA was compared with the levels of potential biomark-
ers in SF, including VEGF and MMP-1 (Anitua et al. 2009). 
This may have been due to the different types of OA scalings 
and/or methods of statistical analysis used.
Correlations involving MCP-1 and IL-1Ra
Coefficients for correlations between levels of mediators in a 
body fluid may give information about the main interaction 
partners in the regulatory protein network of this body fluid. 
Changes in these correlation coefficients during the progres-
sion of OA may reflect molecular variations within signal 
cascades and interaction networks that are involved in the 
progression of the disease. In this study, we measured levels 
of mediators in the SF of OA patients, and correlation coef-
ficients were compared between patients with severe OA and 
those with no or moderate OA (Table 2b vs. Table 2a). Our 
results revealed 2 groups of correlation coefficients that were 
high in severe OA, and MCP-1 and IL-1Ra (respectively) pre-
dominated.
In the first group, there was a strong correlation between 
MCP-1 levels and the levels of MMP-13 and VEGF, but 
there was only a correlation between MCP-1 and VEGF in 
the group with no or moderate OA. Besides other mediators, 
MCP-1, MMP-13, and VEGF were involved in progression 
of OA. MCP-1 has been shown to inhibit proteoglycan syn-
thesis and to enhance proteoglycan release from chondrocytes 
(Yuan et al. 2001). Chondrocytes produce chemokines such 
as MCP-1, MIP-1a, and IL-8 that potentiate chondrocyte 
apoptosis and cartilage degradation in OA (Borzì et al. 2004). 
MMP-13 is expressed by chondrocytes and synovial cells in 
human OA, and is thought to play a critical role in cartilage 
destruction (Takaishi et al. 2008). Experiments in MMP-13 
deficient mice have revealed that structural damage of car-
tilage in OA is dependent on MMP-13 activity (Little et al. 
2009). Our results indicate that there is a dramatically increas-
ing inter-dependence of the levels of MCP-1 and MMP-13 in 
SF during the progression of OA, suggesting that there is a 
relationship between these two mediators during the progres-
sion of the disease.
In the second group, IL-1Ra levels were highly correlated 
with the levels of MMP-9, MIP-1a, IL-8, and HGF, whereas 
IL-1Ra and IL-8 also showed a correlation in the group with 
no or moderate OA. The anti-inflammatory cytokine IL-1Ra 
has been shown to reduce cartilage degradation, MMP pro-
duction, and the progression of OA lesions (Fernandes et al. 
2002) and is a promising candidate for OA therapy (Calich 
et al. 2010). MMP-9 concentrations in the SF correlate well 
with the number and severity of cartilage lesions (Jouglin et al. 
2000). MIP-1a acts directly on cells of the osteoclast lineage 
to stimulate osteoclastogenesis (Watanabe et al. 2004) and 
HGF may contribute to synovial neovascularization (Koch et 
al. 1996). Our results indicate that the correlation between the 
levels of IL-1Ra on the one hand and MMP-9, MIP-1a, and 
HGF on the other increases markedly during the progression 
of OA, suggesting that there is a relationship between IL-1Ra 
and these 3 mediators during disease progression. Expression 
of IL-1Ra by articular tissue cells may act as a counterbalance 
to OA-related phenomena such as inflammation, angiogen-
esis, and cartilage matrix degradation.
In summary, our data show that there is a positive correla-
tion between IL-7 levels in SF and age, especially in patients 
older than 55 years. However, severe OA in all 3 compart-
ments of the knee counteracts this age-related increase in IL-7 
levels, possibly due to widely impaired chondrocytes embed-
ded in the affected cartilage tissue. One may conclude that 
until this stage of cartilage deterioration, IL-7 might act as 
an age-dependent factor for the highly age-related progression 
of OA. MMP-1 levels in SF were found to decrease during 
progression of OA, which could be explained by diminished 
MMP-1 production by chondrocytes embedded in superficial 
cartilage layers, which deteriorate during progression of OA. 
VEGF was the only single mediator that showed a significant 
positive correlation with radiographic OA grading. However, 64  Acta Orthopaedica 2012; 83 (1): 59–64
the interconnection between several mediators was increased 
in severe OA, suggesting that changes in interaction pat-
terns of biochemical mediators in SF may be more relevant 
for disease progression than absolute changes in the levels of 
individual mediators. A deeper understanding of the effects 
of biochemical parameters on the initiation and progression 
of arthritic diseases will help us to find therapeutic targets to 
prevent and treat OA in the future.
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